DR LAL PATHLABS
Back to Cashflow Statement
|
DR LAL PATHLABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-264 Cr | ₹-334 Cr | ₹-414 Cr | ₹-283 Cr | ₹136 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR LAL PATHLABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-264 Cr |
| Mar2025 | ₹-334 Cr |
| Mar2024 | ₹-414 Cr |
| Mar2023 | ₹-283 Cr |
| Mar2022 | ₹136 Cr |
How is Cash Flow from Financing Activities of DR LAL PATHLABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-264 Cr | Negative | |
| Mar2025 | ₹-334 Cr | Negative | |
| Mar2024 | ₹-414 Cr | Negative | |
| Mar2023 | ₹-283 Cr | Negative | |
| Mar2022 | ₹136 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹31,969.7 Cr | 4.5% | 15.5% | 21.5% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹128,759.0 Cr | 1.3% | 3% | 22% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹106,919.0 Cr | -1.4% | -2.6% | -11.1% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹71,638.4 Cr | 2.3% | 4% | 36.9% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹71,328.5 Cr | 0.3% | -3.1% | 12% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹41,435.2 Cr | -1.3% | 2.1% | 4.9% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 4.5% |
15.5% |
21.5% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses